| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 30 May 2024 | 25 Apr 2024 |
| GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31 2024. The notice can be accessed at the Companys website at www.gkb.net Further notice is hereby given with reference to the above meeting of the Board of Directors that the trading window for dealing with equity shares of the company by designated persons under SEBI (Prohibition of Insider Trading) Regulation 2015 had been closed from April 01 2024 will now re-open on MondayJune 03 2024. | ||
| Board Meeting | 22 May 2024 | 22 May 2024 |
| In compliance with the provisions of Regulation 30 read with Schedule III of SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors have passed circular resolutions today, i.e. May 22, 2024 with respect to 1. Appointment of Mrs. Sandhya Ajit Kamat as an Additional Director ( Independent & Non Executive), with effect from May 22, 2024. 2. Retirement of Mr. Anil Palekar , as Independent Non Executive Director of the Company with effect from close of business hours on May 22, 2024, due to completion of his tenure. 3. Reconstitution of the Committees of the Board of Directors. We request you to kindly take note of the same. | ||
| Board Meeting | 19 Mar 2024 | 19 Mar 2024 |
| A separate meeting of the Independent Directors of the Company for the year 2023-24 was held pursuant to Regulation 25(3) of SEBI ( Listing Obligations and Disclosure Requirements ) Regulations, 2015 and Section 149(8) of the Companies Act, 2013, read with Schedule IV(VII). All the Independent Directors were present. The details of the business transacted are enclosed. Kindly take the information on record. Pursuant to Regulation 30 of the Securities and Exchange Board of India ( Listing Obligations and Disclosure Requirements) Regulations, 2015 enclosed please find the disclosure pertaining to the resignation of Mr. Subhash Redkar as Executive / Whole Time Director of the Company w.e.f. March 16, 2024. The Board of Director in its meeting held today, i.e. March 19, 2024, accepted the resignation of Mr. Subhash Redkar as Executive/ Whole Time Director of the Company and thereafter reconstituted the Committees of the Board. The said details and a copy of the resignation letter is enclosed as Annexure A. Kindly take the information on record. | ||
| Board Meeting | 14 Feb 2024 | 30 Jan 2024 |
| GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2023. The Notice can be accessed at the Companys website at www.gkb.net Further notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company by designated persons under the SEBI (Prohibition of Insider Trading) Regulations 2015 which has been closed will now re-open on Monday February 19 2024. This communication has been sent to all the Directors and all the designated employees of the Company. The meeting of the Board of Directors of the Company was held on February 14, 2024, which considered and took on record the Unaudited Standalone and Consolidated Financial Results of the Company for quarter and nine months ended December 31, 2023. Pursuant to Regulation 33 (3)(d) of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, enclosed please find the following : 1. Standalone Financial Results for the quarter and nine months ended December 31, 2023, together with the Limited Review Report. 2. Consolidated Financial Results for the quarter and nine months ended December 31, 2023, together with the Limited Review Report. The Board of Directors Meeting started at 4.45 P.M. and ended at 06.25 P.M., on the same day. Kindly take the information on record. (As Per BSE Announcement Dated on 14/02/2024) | ||
| Board Meeting | 14 Nov 2023 | 30 Oct 2023 |
| GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve Notice is hereby given that a meeting of the Board of Directors of the company will be held on Tuesday November 14 2023 inter alia for considering and taking on record the Unaudited standalone and consolidated Financials Results of the Company for the quarter and half ended September 30 2023. The Notice can be accessed at the Companys website at www.gkb.net. Kindly take the information on record. The meeting of the Board of Directors of the Company was held on November 14, 2023, which considered and took on record the Unaudited Standalone and Consolidated Financial Results of the Company quarter and half year ended September 30, 2023. Pursuant to Regulation 33 (3)(d) of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, enclosed please find the following : 1. Standalone Financial Results for the quarter and half year ended September 30, 2023, together with the Limited Review Report. 2. Consolidated Financial Results for the quarter and half year ended September 30, 2023, along with Limited Review Report. The above Unaudited Financial Results and the Limited Review Reports are available on the Companys website www.gkb.net and on the BSE website www.bseindia.com The Board of Directors Meeting started at 04.00 P.M. and ended at 06.45 P.M., on the same day. (As Per BSE Announcement dated on 14.11.2023) | ||
| Board Meeting | 11 Aug 2023 | 27 Jul 2023 |
| GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2023. The Notice can be accessed at the Companys website at www.gkb.net Further notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company by designated persons under the SEBI (Prohibition of Insider Trading) Regulations 2015 which has been closed will now re-open on Monday August 14 2023. This communication has been sent to all the Directors and all the designated employees of the Company. The meeting of the Board of Directors of the Company was held on August 11, 2023, which considered and took on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2023. Pursuant to Regulation 33 (3) (d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find the following: 1. Standalone Financial Results for the quarter ended June 30, 2023, together with the Limited Review Report 2. Consolidated Financial Results for the quarter ended June 30, 2023, along with Limited Review Report. The above Unaudited Financial Results and the Limited Review Reports are available on the Companys website www.gkb.net and on the BSE website www.bseindia.com . (As Per BSE Announcement Dated on 25.08.2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
